Fu C - Search Results

1

A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China.

Du J, Fang B, Li J, Jin J, Wang S, Zou D, Cai Z, Wang H, Hu J, Li W, Fu C, Shao Z, Xia Z, Liu P, Niu T, Tang ET, Kimball AS, Hou J, Chen W. Du J, et al. Among authors: fu c. Int J Hematol. 2021 Mar;113(3):422-429. doi: 10.1007/s12185-020-03044-z. Epub 2021 Jan 3. Int J Hematol. 2021. PMID: 33389656

2

[Research advances of extramedullary relapse in multiple myeloma - review].

Wang J, Fu CC. Wang J, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Oct;20(5):1261-6. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012. PMID: 23114161 Review. Chinese.

3

[Retrospective analysis on therapeutic effect of autologous hematopoietic stem cell transplantation in multiple myeloma patients].

Wang J, Fu CC, Wu DP, Sun AN, Xue SL, Xin X, Hu XH, Wang Y, Qiu HY, Jin ZM, Miao M, Tang XW, Han Y, Ma X, He GS, Chang WR, Chen SN. Wang J, et al. Zhonghua Yi Xue Za Zhi. 2013 Jan 8;93(2):114-8. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23648347 Chinese.

4

[Efficacy and safety study of subcutaneous injection of bortezomib in the treatment of de novo patients with multiple myeloma].

Liu H, Fu CC, Xue SL, Li WY, Wu Q, Gu B, Jin S, Zhu XM, Zhao SF, Xin X, Ma L, Sun AN, Wu DP. Liu H, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Oct;34(10):868-72. doi: 10.3760/cma.j.issn.0253-2727.2013.10.009. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 24171961 Clinical Trial. Chinese.

5

[Busulfan Combined with Cyclophosphamide as the Conditioning Regimen in Patients with Multiple Myeloma Treated by Autolo-gous Hematopoietic Stem Cell Transplantation].

Jin S, Xu Y, Wang PF, Zhou J, Gu B, Li WY, Zhou HF, Fu CC. Jin S, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Dec;23(6):1618-22. doi: 10.7534/j.issn.1009-2137.2015.06.017. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015. PMID: 26708882 Chinese.

6

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study.

Li J, Bao L, Xia Z, Wang S, Zhou X, Ding K, Zhang W, Yang W, Li B, Fu C, Chen B, Hua L, Wang L, Luo J, Yang Y, Xu T, Wang W, Huang Y, Wu G, Liu P. Li J, et al. Among authors: fu c. Ann Hematol. 2020 Nov;99(11):2589-2598. doi: 10.1007/s00277-020-04234-9. Epub 2020 Sep 6. Ann Hematol. 2020. PMID: 32892275 Free PMC article. Clinical Trial.

7

Sequential CD19 and BCMA-specific CAR T-cell treatment elicits sustained remission of relapsed and/or refractory myeloma.

Yan L, Qu S, Shang J, Shi X, Kang L, Xu N, Zhu M, Zhou J, Jin S, Yao W, Yao Y, Chen G, Chang H, Zhu X, Yu L, Wu D, Fu C. Yan L, et al. Among authors: fu c. Cancer Med. 2021 Jan;10(2):563-574. doi: 10.1002/cam4.3624. Epub 2020 Dec 23. Cancer Med. 2021. PMID: 33356013 Free PMC article.

8

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study.

Lu J, Fu W, Li W, Hu J, An G, Wang Y, Fu C, Chen L, Jin J, Cen X, Ge Z, Cai Z, Niu T, Qi M, Sun S, Gai X, Liu W, Liu W, Yang X, Huang X. Lu J, et al. Among authors: fu c, fu w. Clin Lymphoma Myeloma Leuk. 2021 Sep;21(9):e699-e709. doi: 10.1016/j.clml.2021.04.012. Epub 2021 Apr 24. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34108127 Free article. Clinical Trial.

9

Outcomes of severe aplastic anemia patients with infection proceeding with allogeneic hematopoietic stem cell transplantation, versus patients without infection.

Liu L, Miao M, Chen X, Zhang Y, Lei M, Li B, Zhou H, Wang Q, Qiu H, Tang X, Han Y, Fu C, Jin Z, Chen S, Sun A, Wang S, Wu D. Liu L, et al. Among authors: fu c. Bone Marrow Transplant. 2021 Oct;56(10):2591-2594. doi: 10.1038/s41409-021-01398-4. Epub 2021 Jul 3. Bone Marrow Transplant. 2021. PMID: 34218267 No abstract available.

10

[Application of Conditioning Regimen with Busulfan and Cyclophosphamide in Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma].

Xu Y, Zhou J, Ma L, Jin S, Yan LZ, Shang JJ, Wu DP, Fu CC. Xu Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Dec;29(6):1831-1836. doi: 10.19746/j.cnki.issn.1009-2137.2021.06.024. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021. PMID: 34893119 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,534 results

Search Page